Recombinant Factor C endotoxin detection technology is crucial in pharmaceutical manufacturing for enhancing product safety and supporting sustainability goals.

Learn the standards and regulations for testing recombinant factor C endotoxins.

Recombinant protein therapy articles from across Nature Portfolio A recombinant protein therapy is produced through recombinant DNA technology, which involves inserting the DNA encoding the ...

A high plasma level of factor VIII is a risk factor for venous thromboembolism. We evaluated the risk of a recurrence of thrombosis after an initial episode of spontaneous venous thromboembolism am ...

Recombinant human EPO regimens of 40–150 U/kg intravenously three times a week have been studied for prevention or treatment of uremic bleeding. [61, 62, 64] The goal of treatment with ...

Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in the next five years.

The glycosaminoglycans (GAGs) heparan sulfate, dermatan sulfate, and heparin are important anticoagulants that inhibit clot formation through interactions with antithrombin and heparin cofactor II.

A 69-year-old woman was referred to the retina service for abnormal posterior segment findings.The patient’s medical history was notable for bilateral hearing loss and type 2 diabetes ...